Douglas S. Burgoyne, PharmD, FAMCP

This activity is supported by an educational grant from Sandoz Inc.

Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity

After completing this continuing education program, the participant will be able to:

Examine current treatment options in rheumatoid arthritis (RA) and steps to address and/or minimize treatment failure

Identify emerging treatment pathways in RA and associated pathways

Explain the requirements necessary for a biosimilar agent to be approved for use

Illustrate methods to improve care for patients with RA

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-059-H01-P. The activity is available for CE credit through June 15, 2018.

Articles

This Continuing Education activity is supported by an educational grant from Sandoz Inc.